Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120

被引:17
|
作者
Kirchherr, Jennifer L. [1 ,2 ]
Hamilton, Jennifer [1 ,2 ]
Lu, Xiaozhi [1 ,2 ]
Gnanakaran, S. [4 ]
Muldoon, Mark [5 ]
Daniels, Marcus [4 ]
Kasongo, Webster [6 ]
Chalwe, Victor [6 ]
Mulenga, Chanda [6 ]
Mwananyanda, Lawrence [6 ]
Musonda, Rosemary M. [6 ]
Yuan, Xing [3 ]
Montefiori, David C. [3 ]
Korber, Bette T. [4 ,7 ]
Haynes, Barton F. [1 ,2 ]
Gao, Feng [1 ,2 ]
机构
[1] Duke Univ, Duke Human Vaccine Inst, Med Ctr, Durham, NC 27710 USA
[2] Duke Univ, Dept Med, Med Ctr, Durham, NC 27710 USA
[3] Duke Univ, Dept Surg, Med Ctr, Durham, NC 27710 USA
[4] Los Alamos Natl Lab, Los Alamos, NM 87545 USA
[5] Univ Manchester, Sch Math, Manchester M13 9PL, Lancs, England
[6] Trop Dis Res Ctr, Ndola, Zambia
[7] Santa Fe Inst, Santa Fe, NM 87501 USA
基金
美国国家卫生研究院;
关键词
HIV-1; Envelope; Genetic variation; Neutralization; Signature; HUMAN MONOCLONAL-ANTIBODIES; CROSS-CLADE NEUTRALIZATION; ENVELOPE GLYCOPROTEIN; ENV CLONES; POINT MUTATIONS; HIV-1; VACCINE; GP41; TRANSMISSION; INFECTION;
D O I
10.1016/j.virol.2010.09.031
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Neutralizing antibodies (Nabs) are thought to play an important role in prevention and control of HIV-1 infection and should be targeted by an AIDS vaccine. It is critical to understand how HIV-1 induces Nabs by analyzing viral sequences in both tested viruses and sera. Neutralization susceptibility to antibodies in autologous and heterologous plasma was determined for multiple Envs (3-6) from each of 15 subtype-C-infected individuals. Heterologous neutralization was divided into two distinct groups: plasma with strong, cross-reactive neutralization (n=9) and plasma with weak neutralization (n=6). Plasma with cross-reactive heterologous Nabs also more potently neutralized contemporaneous autologous viruses. Analysis of Env sequences in plasma from both groups revealed a three-amino-acid substitution pattern in the V4 region that was associated with greater neutralization potency and breadth. Identification of such potential neutralization signatures may have important implications for the development of HIV-1 vaccines capable of inducing Nabs to subtype C HIV-1. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:163 / 174
页数:12
相关论文
共 50 条
  • [1] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZATION IS DETERMINED BY EPITOPE EXPOSURE ON THE GP120 OLIGOMER
    SATTENTAU, QJ
    MOORE, JP
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01): : 185 - 196
  • [2] Identification of complement activation sites in human immunodeficiency virus type-1 glycoprotein gp120
    Susal, C
    Kirschfink, M
    Kropelin, M
    Daniel, V
    Opelz, G
    BLOOD, 1996, 87 (06) : 2329 - 2336
  • [3] MODEL FOR INTRACELLULAR FOLDING OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 GP120
    FENNIE, C
    LASKY, LA
    JOURNAL OF VIROLOGY, 1989, 63 (02) : 639 - 646
  • [4] MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP41 AFFECT SENSITIVITY TO NEUTRALIZATION BY GP120 ANTIBODIES
    BACK, NKT
    SMIT, L
    SCHUTTEN, M
    NARA, PL
    TERSMETTE, M
    GOUDSMIT, J
    JOURNAL OF VIROLOGY, 1993, 67 (11) : 6897 - 6902
  • [5] PRIMARY ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ARE RELATIVELY RESISTANT TO NEUTRALIZATION BY MONOCLONAL-ANTIBODIES TO GP120, AND THEIR NEUTRALIZATION IS NOT PREDICTED BY STUDIES WITH MONOMERIC GP120
    MOORE, JP
    CAO, YZ
    QING, L
    SATTENTAU, QJ
    PYATI, J
    KODURI, R
    ROBINSON, J
    BARBAS, CF
    BURTON, DR
    HO, DD
    JOURNAL OF VIROLOGY, 1995, 69 (01) : 101 - 109
  • [6] RESISTANCE TO NEUTRALIZATION BY BROADLY REACTIVE ANTIBODIES TO THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 GLYCOPROTEIN CONFERRED BY A GP41 AMINO-ACID CHANGE
    THALI, M
    CHARLES, M
    FURMAN, C
    CAVACINI, L
    POSNER, M
    ROBINSON, J
    SODROSKI, J
    JOURNAL OF VIROLOGY, 1994, 68 (02) : 674 - 680
  • [7] IDENTIFICATION AND CHARACTERIZATION OF A NEUTRALIZATION SITE WITHIN THE 2ND VARIABLE REGION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120
    FUNG, MSC
    SUN, CRY
    GORDON, WL
    LIOU, RS
    CHANG, TW
    SUN, WNC
    DAAR, ES
    HO, DD
    JOURNAL OF VIROLOGY, 1992, 66 (02) : 848 - 856
  • [8] CHARACTERIZATION OF CONSERVED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 NEUTRALIZATION EPITOPES EXPOSED UPON GP120-CD4 BINDING
    THALI, M
    MOORE, JP
    FURMAN, C
    CHARLES, M
    HO, DD
    ROBINSON, J
    SODROSKI, J
    JOURNAL OF VIROLOGY, 1993, 67 (07) : 3978 - 3988
  • [9] FUNCTIONAL INTERACTION OF CONSTANT AND VARIABLE DOMAINS OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 GP120
    WILLEY, RL
    ROSS, EK
    BUCKLERWHITE, AJ
    THEODORE, TS
    MARTIN, MA
    JOURNAL OF VIROLOGY, 1989, 63 (09) : 3595 - 3600
  • [10] EPITOPE MAPPING OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 GP120 WITH MONOCLONAL-ANTIBODIES
    DOWBENKO, D
    NAKAMURA, G
    FENNIE, C
    SHIMASAKI, C
    RIDDLE, L
    HARRIS, R
    GREGORY, T
    LASKY, L
    JOURNAL OF VIROLOGY, 1988, 62 (12) : 4703 - 4711